€227m for Aids research
The collaboration is critical to making HIV vaccine development more efficient, said Dr Nicholas Hellmann, acting director of the Gates Foundation’s HIV, TB and reproductive health programme in Seattle.
Dr Hellmann acknowledged that an effective vaccine may still be 10 years away.